Dr. Anthony Capobianco, who got his PhD with Tom Gilmore in Biology, is currently a Professor at the Sylvester Comprehensive Cancer Center of the University of Miami, and is President of the Biotech Company StemSynergy Therapeutics. His research on new therapeutics directed against cancer stem cells, especially for the treatment of esophogeal and certain breast cancers, was recently featured in Business Wire and was published in Cancer Research.

Posted 2 years ago on in Alumni News, News